Article
Gastric Cancer Cell Glycosylation as a Modulator of the ErbB2 Oncogenic Receptor
28 Oct 2017
Abstract excerpt
Aberrant expression and hyperactivation of the human epidermal growth factor receptor 2 (ErbB2) constitute crucial molecular events underpinning gastric neoplastic transformation. Despite ErbB2 extracellular domain being a well-known target for glycosylation, its glycosylation profile and the molecular mechanisms through which it actively tunes tumorigenesis in gastric cancer (GC) cells remain elusive. We aimed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
